Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Experimental hypothermia with drug-induced shivering inhibition in healthy volunteers
2023-506020-81-00Phase 2Completed
- Sponsor
- Helse Bergen
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pethidine and buspirone in Hypothermia (2 arms), sponsored by Helse Bergen. Primary endpoint: Core temperature at termination of cooling. Started Oct 2023; status: completed.
02
Drugs
pethidinebuspirone
03
Conditions
Hypothermia
Beyond the preview
Go deeper on 2023-506020-81-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-506020-81-00.